Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Possible applications of circulating tumor cells in patients with non small cell lung cancer.

Lung cancer (Amsterdam, Netherlands) - 1 May 2017

Tartarone Alfredo, Rossi Elisabetta, Lerose Rosa, Mambella Giuseppina, Calderone Giuseppe, Zamarchi Rita, Aieta Michele

Abstract excerpt

Recent experiences indicate that, as already reported for other types of cancer, circulating tumor cells (CTCs) may play a role also in non small cell lung cancer (NSCLC) for diagnosis, therapy monitoring and prognostic purposes. CTCs evaluation could be particularly relevant in this clinical setting not only for the objective difficulty in obtaining tumor tissue, but also because of the lack of reliable tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Count

Share to Clinical Decision-Making

Share to ErbB Receptors

Share to Liquid Biopsy

Share to Neoplastic Cells, Circulating

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 27339469
DOI: 10.1016/j.lungcan.2016.05.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Possible applications of circulating tumor cells in patients with non small cell lung cancer.PMID 27339469Read ↗

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patientsSemantic proximity Read ↗

A case of residual non-small cell lung cancer cells coexisting with newly developed small cell lung cancer cells in ascitic fluid after chemotherapy for non-small cell lung cancer.Semantic proximity Read ↗

Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer.Semantic proximity Read ↗

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line ChemotherapySemantic proximity Read ↗

Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.Semantic proximity Read ↗

Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice.Semantic proximity Read ↗

Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patientsSemantic proximity Read ↗

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab.Semantic proximity Read ↗

Cell lines from circulating tumor cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.